InvestorsHub Logo
Followers 0
Posts 44
Boards Moderated 0
Alias Born 03/15/2017

Re: None

Wednesday, 04/12/2017 6:52:13 PM

Wednesday, April 12, 2017 6:52:13 PM

Post# of 21531
According to the (conservatively priced) Aegis product model, NTRP is expected to have an EPS of $9.86 based on 163,625 patients/year in 2022.

According to Bloomberg, there will be over 50 million people worldwide suffering from AD:

https://www.bloomberg.com/news/articles/2017-03-01/elusive-alzheimer-s-therapy-leads-drugmakers-to-abandon-caution

If NTRP manages to treat even 10% of the market, they would have 5 million patients a year, which is 30.5576776165 times more than 163,625.

$9.86 * 30.5576776165 = $301.3

With a P/E ratio of 15, each share would then be worth $4519.5.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News